Prospera Financial Services Inc Hepion Pharmaceuticals, Inc. Transaction History

Prospera Financial Services Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.57 - $1.22 $4,560 - $9,760	-8,000 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.93 - $1.29 $7,440 - $10,320	8,000 New	8,000 $10,000
Q4 2021 Feb 10, 2022	SELL	$1.14 - $1.58 $34,542 - $47,874	-30,300 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$1.56 - $2.26 $1,560 - $2,260	-1,000 Reduced 3.19%	30,300 $60,000
Q1 2021 May 06, 2021	SELL	$1.77 - $2.98 $14,160 - $23,840	-8,000 Reduced 20.36%	31,300 $58,000
Q4 2020 Feb 12, 2021	BUY	$1.58 - $3.64 $62,094 - $143,052	39,300 New	39,300 $86,000
Q3 2020 Nov 04, 2020	SELL	$2.84 - $4.59 $95,992 - $155,142	-33,800 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$1.31 - $3.09 $1,310 - $3,090	-1,000 Reduced 2.87%	33,800 $97,000
Q1 2020 May 15, 2020	BUY	$1.15 - $5.74 $24,940 - $124,483	21,687 Added 165.39%	34,800 $62,000
Q4 2019 Feb 12, 2020	BUY	$2.25 - $6.99 $29,504 - $91,659	13,113 New	13,113 $70,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.